Ga-68-DOTATOC Solution for injection Ref.[10295] Active ingredients: Gallium ⁶⁸Ga edotreotide

Source: FDA, National Drug Code (US)  Revision Year: 2019 

Product description

11.1 Chemical Characteristics

Ga 68 DOTATOC Injection is a radioactive diagnostic agent for intravenous administration. It contains 3.6 mcg/mL (DOTA-0-Phe1-Tyr3) octreotide, 18.5 MBq/mL to 148 MBq/mL (0.5 mCi to 4 mCi/mL) of Ga 68 DOTATOC at calibration time, and ethanol (10% v/v) in sodium chloride (9 mg/mL) solution (approximately 14 mL volume). Ga 68 DOTATOC Injection is a sterile, pyrogen free, clear, colorless, buffered solution, with a pH between 4 to 8.

Ga 68 DOTATOC, also known as Gallium-68 (DOTA0-Phe1-Tyr3) octreotide, is a cyclic 8 amino acid peptide with a covalently bound chelator (DOTA). The peptide has the amino acid sequence: H-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH, and contains one disulfide bond. Ga 68 DOTATOC has a molecular weight of 1489.65 g/mol and its chemical structure is shown in Figure 1.

Figure 1. Chemical Structure of Ga 68 DOTATOC:

Gallium-68 labeled 2-[4-[2-[[(2R)1[[(4R,7S,10S,13R,16S,19R)10(4-aminobutyl)4[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]7[(1R)-1-hydroxyethyl]16[(4-hydroxyphenyl)methyl]13(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid.

11.2 Physical Characteristics

Table 3 and Table 4 display the principal radiation emission data and physical decay of Ga 68.

Gallium-68 (Ga 68) decays with a half-life of 68 minutes to stable Zn 68:

  • 89% through positron emission with a mean energy of 836 keV followed by emission of two 511 keV annihilation photons (178%),
  • 10% through orbital electron capture (with associated X-ray or Auger emissions), and
  • 3% through 13 gamma transitions from 5 excited levels of the daughter Zn 68 nucleus. The most probable prompt gamma emission is a 1088 keV gamma with a 3.2% per decay probability.

Table 3. Principal Radiation Emission Data (>1%):

Radiation/Emission % Disintegration Mean Energy (MeV)
beta+ 88% 0.8360
beta+ 1.1% 0.3526
gamma 178% 0.5110
gamma 3% 1.0770
X-ray 2.8% 0.0086
X-ray 1.4% 0.0086

Table 4. Physical Decay Chart for Gallium Ga-68:

Minutes Fraction Remaining
0 1.000
15 0.858
30 0.736
60 0.541
90 0.398
120 0.293
180 0.158
360 0.025

11.3 External Radiation

Gamma constant: 1.8 × 10-4 mSv/hr per MBq at 1 meter [0.67 mrem/hr per mCi at 1 meter]. Table 5 displays the radiation attenuation by lead shielding of Ga 68.

Table 5. Radiation Attenuation of 511 keV Photons by Lead (Pb) Shielding:

Shield Thickness
(Pb) mm
Coefficient of Attenuation
6 0.5
12 0.25
17 0.1
34 0.01
51 0.001
Dosage Forms and Strengths

Injection: Gallium Ga 68 DOTATOC Injection is a clear, colorless solution in a 30 mL multiple-dose vial containing 18.5 MBq/mL to 148 MBq/mL (0.5 mCi/mL to 4 mCi/mL) of Ga 68 DOTATOC Injection at calibration date and time.

How Supplied

Ga 68 DOTATOC Injection is supplied in a multiple-dose, capped 30 mL glass vial containing 18.5 MBq/mL to 148 MBq/mL (0.5 mCi/mL to 4 mCi/mL) of Ga 68 DOTATOC at calibration time in approximately 14 mL of solution (NDC 24417-681-30).

Drugs

Drug Countries
Ga-68-DOTATOC United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.